excluded. Out of the total 144 patients, 110 were male (76.4 %) and the mean age was 42±15 yr (range: 11-82 yr).
Study Design
We retrospectively studied medical records of the patients with HFRS. We obtained medical records of clinical symptoms and signs and the following laboratory values from each patient with HFRS; hemoglobin, hematocrit, platelet count, leukocyte count, blood urea nitrogen (BUN), serum creatinine, serum albumin level, serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels, and proteinuria and 24 hr urine protein amount. We also evaluated plain chest and abdomen radiography and abdominal ultrasonography. Finally, we investigated the episodes of hypotension, admission duration, and outcome from the patients. Hypotension was defined as systolic pressure below 90 mmHg. Hypoalbuminemia was defined as a serum albumin less than 3.5 g/ dL. Thrombocytopenia was defined as a platelet count below 100,000/ L. Leukocytosis was defined as a leukocyte count over 10,000/ L. Acute renal failure was defined as a serum creatinine over 2 mg/dL. Abnormal liver function was defined as an AST or ALT over 80 IU/L. Platelet transfusion was performed, when there was severe thrombocytopenia less than 50,000/ L or hemorrhagic manifestation or central vein cannulation for hemodialysis in case of moderate thrombocytopenia more than 50,000/ L. Hemodialysis treatment was individualized according to the degree of acute renal failure and volume status. The patients were divided into three groups based on the level of serum albumin; Group I (normal serum albumin), Group II (serum albumin <3.5 g/dL and ≥3.0 g/dL), and Group III (serum albumin <3.0 g/dL). Laboratory and clinical values were then compared among the three groups, and the correlation between the lowest level of serum albumin and laboratory values was evaluated.
Statistical Analysis
Data were expressed as mean±standard deviation (SD). The differences among groups were analyzed by a one-way analysis of variance (ANOVA), followed by Schffe' s test for multiple comparisons. Pearson' s correlation coefficient was used to determine the relationship between the lowest level of serum albumin and laboratory values. The significance of differences between proportions was tested by the chi-square test. Statistical significance was defined as p<0.05.
RESULTS

Clinical Characteristics
Indirect immunofluorescence antibody tests against the Hantavirus were positive in all patients. (n=2), and intracranial hemorrhage (n=1). Ten (6.9%) patients were expired due to hypotensive shock (n=8), pulmonary hemorrhage (n=1), and intracranial hemorrhage (n=1). Mean duration value of the admission among the survivors (n=134) was 11.6±7.7 days (2-57 days).
Incidence of Hypoalbuminemia
The rate of incidence of hypoalbuminemia at admission developed in 89 (61.8%) patients and increased up to 70.8% after admission. The level of serum albumin at admission (3.2 ±0.4 g/dL) also decreased to 3.1±0.4 g/dL after admission. Based on the lowest level of serum albumin, 42 (29.2%) patients were categorized as Group I (normal serum albumin), 39 (27.1%) as Group II (serum albumin <3.5 g/dL and ≥3.0 g/dL), and 63 (43.8%) as Group III (serum albumin <3.0 g/ dL). The patients in Group III were older than those in Group I (50±17 vs. 37±11, p<0.01) and Group II (50±17 vs. 36 ±11 yr, p<0.05), but there was no statistical difference between Groups I and II. There was no statistical difference in Hb, hemoglobin; Hct, hematocrit; WBC, white blood cell; Plt, platelet; BUN, blood urea nitrogen; Scr, serum creatinine; AST, aspartate aminotransferase; ALT, alanine aminotrasferase; Alb, serum albumin; Upro, amount of 24 hr urine protein. The lowest level of serum albumin was positively correlated with platelet count (r=0.505, p<0.001), and was negatively correlated with leukocyte count (r=-0.329, p<0.001), and BUN (r=-0.484, p<0.001), and serum creatinine (r=-0.394, p<0.001), and AST (r=-0.251, p=0.002). But there was no correlation between the lowest level of serum albumin and hemoglobin (r=0.058, p=0.491), hematocrit (r=0.050, p= 0.553), ALT (r=-0.120, p=0.153), and amount of 24 hr urine protein (r=-0.090, p=0.361) (Fig. 1) .
Comparison of Clinical Values and Mortality according to the Lowest Level of Serum Albumin
The rate of incidence of hypotension in Group III was higher than that of Group I (0%) and that of Group II (7.6%). The rate of incidence of acute renal failure in Groups II (94.8%) and III (92.1%) were higher than that of Group I (42.8%), and while more patients from Group III (60.3%) received hemodialysis treatment than did the patients from Group I (0%) and Group II (34.8%). Group I had a higher rate of incidence of thrombocytopenia and a higher incidence of platelet transfusion, when compared to Group II and Group III. Group I had a higher rate of incidence of abnormal liver function, compared to group III, but there was no statistical difference between Groups I and II. Group III had a higher rate of incidence of pulmonary edema, when compared to Groups I and II. All patients who were expired were in Group III, and the duration of admission of the survivors from Group III (15.2 ±9.4 days) was longer than that of Group I (7.9±4.6 days) and that of Group II (10.5±5.5 days) ( Table 2) .
DISCUSSION
Hypoalbuminemia frequently occurs in the acute stage of HFRS, but its significance is rarely reported until now. To evaluate the relationship between the level of serum albumin and the severity of disease in patients with HFRS, we have studied 148 patents with HFRS in a single center. Our data demonstrated that hypoalbuminemia frequently occurred in the acute stage of HFRS, and the lowest level of serum albumin was associated with the severity of disease of HFRS. To our knowledge, this is the first report demonstrating the relation between the level of serum albumin and the severity of disease of HFRS.
Hemodynamic alterations leading to hypotension and shock have been well characterized in patients with HFRS. These alterations appear to be the consequence of widespread vascular dysfunction, including impaired vascular tone and increased vascular permeability (4). Marked capillary congestion and the episode of hypotension reflect the impairment of vascular tone, while retroperitoneal edema, pleural effusion, ascites, and pericardial effusion reflect the vascular leakage due to increased vascular permeability (5) . Increased vascular permeability has been confirmed by tracer studies of blood and plasma volume (12) . Vascular endothelial cell injury is an important cause of thrombocytopenia. Besides these clinical factors, severe acute renal failure requiring hemodialysis, leukocytosis, abnormal liver function, encephalopathy, sepsis, anuria, acidosis, electrolyte abnormality, proteinuria of long duration, increased hematocrit during hypotensive stage are reported to represent the severity of disease of HFRS (4) (5) (6) (7) (8) (9) .
Although the mechanism of hypoalbuminemia in patients with HFRS is not well known until now, it is considered to be associated with protein leakage through the vessel wall due to increased vascular permeability (4). We first demonstrated the loss of protein via intestinal tracts in the acute stage of HFRS by abdominal scintigraphy using technetium-99m-labeled human serum albumin and fecal clearance of alpha1-antitrypsin and it was associated with serum albumin level and clinical parameters representing increased vascular permeability (10) . We also reported that hypoalbuminemia was associated with gallbladder wall edema in the acute stage of HFRS (13) .
Based on these findings, we hypothesized that hypoalbuminemia in the acute stage of HFRS might be associated with the increased vascular permeability in patients of HFRS. We also studied the relationship between the level of serum albumin and clinical parameters representing the severity of disease. The lowest level of serum albumin was found to be associated with clinical parameters representing the severity of disease (hypotension, thrombocytopenia, leukocytosis, acute renal failure, abnormal liver function, pulmonary edema, and pleural effusion). Therefore, we suggest that hypoalbuminemia, which commonly occurs in acute stage of HFRS, is associated with the severity of disease of HFRS.
We also evaluated whether the lowest level of serum albumin influences on the morbidity and mortality in patients with HFRS. In this study, ten patients (6.9%) out of the total of 144 patients with HFRS died, and most of them (n=8) died from hypotensive shock. This mortality ratio in patients with HFRS was similar to other reports (2, 3, 14) . To evaluate the impact of serum albumin on the morbidity and mortality in patients of HFRS, we divided the patients into three groups based on the lowest level of serum albumin; Group I (normal serum albumin), Group II (serum albumin <3.5 g/dL and ≥ 3.0 g/dL), and Group III (serum albumin <3.0 g/dL). And then we compared the factors among the three groups. Group III had a higher rate incidence of episode of hypotension, pulmonary edema, and pleural effusion than did other groups. Duration of admission of survivors from Group III (15.2± 9.4 days) was longer than that of Group I (7.9±4.6 days) and that of Group II (10.5±5.5 days). All ten patients who died of HFRS were in Group III (p<0.01). Therefore, our data suggest that the level of serum albumin is associated with morbidity and mortality in patients with HFRS.
Interestingly, the amount of proteinuria did not correlate with serum albumin level in this study. Furthermore, it was not associated with the severity of renal failure. The loss of urinary protein in patients with HFRS results from both tubular and glomerular injury (4, 15) . Proteinuria frequently occurs in the acute stage of with HFRS, but the amount of proteinuria is usually mild and transient. In addition, it is reported that the amount of proteinuria in patients with HFRS does not correlate with the severity of renal biopsy findings (16) . In this study, the mean amount of proteinuria was 1.93± 1.66 g/day, and was similar to the other reports (17) . It did not correlate with the severity of renal failure and the level of serum albumin. Furthermore, it completely disappeared in most patients within 7 days. Therefore, we think, besides urinary protein loss, that other factors such as intestinal protein loss or increased catabolism of protein as a consequence of negative acute phase response of serum albumin may contribute to hypoalbuminemia.
In conclusion, our data suggest that hypoalbuminemia frequently occurs in the acute stage of HFRS and the lowest level of serum albumin is closely associated with the clinical parameters representing disease severity and mortality. But it does not correlate with the amount of proteinuria.
